FCM
PGEN icon

Farallon Capital Management’s Precigen PGEN Stock Holding History

Farallon Capital Management’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-50,000
Closed -$194K – 160
2026
Q1 		$194K Hold
50,000
– – ﹤0.01% 149
2025
Q4 		$209K Buy
+50,000
New +$193K ﹤0.01% 135

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Farallon Capital Management's PGEN Position: Q2 2026 in Review

Farallon Capital Management sold out of Precigen (PGEN) in Q2 2026, closing a stake of 50,000 shares — an estimated $194K sold.

Farallon Capital Management first reported a position in PGEN in Q4 2025 and held it in 2 quarters. The position peaked at $209K in Q4 2025. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Farallon Capital Management reported no remaining Precigen position as of Q2 2026 after selling out during the quarter.
  • Farallon Capital Management sold 50,000 Precigen shares in Q2 2026, an estimated $194K.
  • Farallon Capital Management first reported a position in Precigen in Q4 2025 and held it in 2 quarters.
  • Farallon Capital Management's Precigen position peaked at $209K in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Farallon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.